Navigation Links
One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines
Date:9/2/2014

C. [PREFER in AF abstract P6250 for ESC Congress 2014]. 2014.
  • Zamorano, J.L. et al. Trends in antithrombotic management of atrial fibrillation after the last update of ESC guidelines: follow-up data from the PREFER in AF registry. [PREFER in AF abstract P6266 for ESC Congress 2014]. 2014.
  • Camm, A. et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2012;33:2719-2747.
  • Kirchhof P, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). Europace 2013. doi: 10.1093/europace/eut263.
  • Mavrakanas, T., Bounameaux, H. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacology & Therapeutics. 2011;130:46-58.
  • Furugohri, T. et al. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. Journal of Thrombosis and Haemostasis. 2008;6:1542-9.
  • Camm, A. et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal. 2010;31:2369-429.
  • Le Heuzey et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Thromb Haemost. 2014;111(5):833-41.
  • Prolongation PREFER in AF. European Multinational Prolongation Registry on Prevention of Thromboembolic Events in Atrial Fibrillation. DSE-EAF-01-13. Data on file.
  • PREFER in AF. European Multinational Registry on Prevention of Thromboembolic Events in Atrial Fibrillation. DSE-EAF-01-11.  Data on file.
  • Patient.co.uk. Atrial Fibrillation. http://www.pati
    '/>"/>

  • SOURCE Daiichi Sankyo Europe GmbH
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Diplomat signs agreement with oncology management firm Physician Resource Management, Inc. as preferred specialty pharmacy network provider
    2. Virobay Completes $8 Million Series B Preferred Stock Financing
    3. New Study: Medicare Preferred Pharmacy Network Plans Offer Lower Average Premiums, Same Quality as Non-Preferred Network Plans
    4. Surgical Notes Selected as Preferred Transcription Vendor for United Surgical Partners
    5. CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings
    6. Southcoast Health Systems Re-selects JACO as Preferred Mobile Cart Supplier
    7. Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock
    8. Cell Therapeutics Announces Sale of Convertible Preferred Stock
    9. ULURU Inc. Completes Redemption Of Preferred Stock
    10. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
    11. Cardium Completes Preferred Stock Financing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
    (Date:8/28/2015)... Research and Markets ... the "12th Annual Report and Survey of ... their offering. The 2015 12th Annual ... Production is the most recent study of biotherapeutic ... future capacity and production. The report contains the ...
    (Date:8/28/2015)... 28, 2015 Research ... of the "Investigation Report on China,s Insulin ... Developed by Novo Nordisk, insulin aspart ... important drug for the treatment of diabetes. Compared ... acting insulin analog, starts working fast and reports ...
    Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
    ... 2011 CeNeRx BioPharma, Inc., a clinical-stage company developing ... nervous system (CNS), today announced FDA approval of its ... for CXB909, a novel agent that has demonstrated utility ... is a small molecule, orally active agent that enhances ...
    ... 9, 2011 Concentric Medical, Inc. today announced that the ... RE vascularization of large V essel O ... and at Capital Health in Trenton, New Jersey. Oregon Health ... Capital Health was first to use the Trevo device. TREVO ...
    Cached Medicine Technology:CeNeRx Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study 2CeNeRx Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study 3Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial 2Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial 3
    (Date:8/29/2015)... ... , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of Policy ... present an educational program titled “Asbestos and Your Health.” , The two and one ... at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA 19002. ...
    (Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , Eau ... shipping costs. , “Before, a threshold of $49.00 was required to qualify for free ... qualify for free standard shipping for customers regardless of the item’s selling price.” , ...
    (Date:8/29/2015)... ... 29, 2015 , ... The popular television program VOICES IN AMERICA, hosted by ... will be devoting an entire short segment to the subject of diabetes. Diabetes is ... on a daily basis, but recent advancements in medical science may prove to be ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... Day at the Zoo to celebrate children helping children, a thank you to ... throughout West Ohio have contributed to the United Methodist initiative to end malaria ...
    (Date:8/28/2015)... Church, VA (PRWEB) , ... ... ... Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and Best ... Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned ...
    Breaking Medicine News(10 mins):Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5
    ... Rival JoAnne,s Bed & Back; Merger Sets Up Healthy ... Largest Company Owned Back Retail Chain, LORTON, Va., ... focus on home and workplace back wellness created an,ergonomic ... Bed & Back. Healthy Back,s 18 stores and ecommerce ...
    ... This release is,being sent in a social media format, by ... the NIH., News:, * A new study being ... (Abstract #4020), may change treatment practice,in about 25 percent of ... to the way colorectal cancers will be staged., * ...
    ... sufferers gain benefit from calcitriol, an oral form , , FRIDAY, ... cut the risk of death for people with moderate to ... study suggests. , During a two-year study of more ... form of activated vitamin D, had their overall risk of ...
    ... Million for Life-threatening,Disease, BETHESDA, Md., May 16 ... for cystic fibrosis this weekend -- May 17 ... largest national CF,fund-raiser, the Cystic Fibrosis Foundation announced ... Month. Cystic fibrosis is a,life-threatening genetic disease that ...
    ... who would benefit most from chemo after surgery, study says ... 15 genes may help determine which patients with early-stage non-small ... the most from chemotherapy, a new study shows. , ... with less aggressive forms of the cancer who would be ...
    ... Millions of Children Still in Danger, NEW YORK, ... The,Advertising Council today announced a partnership to distribute and ... by A-List,celebrities, including Ben Stiller, Nicole Ritchie, Joel Madden, ... help survivors of the,Myanmar cyclone. The Ad Council is ...
    Cached Medicine News:Health News:The Back Wars Come to a Close 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3
    ... 6 is an enzyme immunoassay (EIA) test ... various specific nuclear antigens (SS-A, SS-B, RNP/Sm, ... is used as an aid in the ... connective tissue disease (MCTD), Sjgren's syndrome and ...
    The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
    The PalmSAT® 2500 series are small, yet versatile digital pulse oximeters for accurate assessment of blood oxygen saturation and pulse rate. Choose alarm or non-alarm versions for your portable ...
    The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
    Medicine Products: